Home › Intestinal Cancer › Massachusetts › Boston

Intestinal Cancer clinical trials in Boston, MA

4 studies for Intestinal Cancer are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

RecruitingPhase 3

Brigham and Women's Hospital (BWH), Boston
Dana-Farber Cancer Institute (DFCI), Boston

Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07222800

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RecruitingPhase 1/2

Dana Farber Cancer Institute, Boston

Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

RecruitingPhase 1/2

Massachusetts General Hospital,, Boston

Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

RecruitingPhase 1/2

Dana Farber Cancer Institute, Boston

Ages 18 and older · All sexes · Updated May 15, 2026 · NCT05379985

About Intestinal Cancer

There are five types of small intestine cancer. Find out how your diet and health history can affect your risk. Learn about intestinal cancer here.

More about Intestinal Cancer on MedlinePlus

Intestinal Cancer trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.